Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Prognostic value of initial PET parameters regarding disease-free survival and overall survival in patients with esophageal squamous cell carcinoma

Charles Lemarignier, Frédéric Di Fiore, Pierre Vera, Bernard Dubray and Pierre Michel
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 72;
Charles Lemarignier
1Centre Henri Becquerel, Rouen, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédéric Di Fiore
2Centre Hospitalo-Universitaire, Rouen, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Vera
1Centre Henri Becquerel, Rouen, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Dubray
1Centre Henri Becquerel, Rouen, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Michel
2Centre Hospitalo-Universitaire, Rouen, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 72

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Charles Lemarignier1,
  2. Frédéric Di Fiore2,
  3. Pierre Vera1,
  4. Bernard Dubray1 and
  5. Pierre Michel2
  1. 1Centre Henri Becquerel, Rouen, France
  2. 2Centre Hospitalo-Universitaire, Rouen, France

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Mar 2015300
Apr 2015100
May 2015100
Sep 20151100
Oct 2015200
Jan 2016200
Jul 2016100
Sep 2016100
Oct 2016300
Nov 2016200
Dec 2016200
Feb 2017300
Mar 2017100
Apr 2017100
Aug 2017100
Oct 2017100
Apr 2018200
Sep 2018200
Oct 2018100
Jan 2019600
Nov 2019200
Dec 2019300
Jan 2020200
Feb 2020500
Mar 20201400
Apr 2020900
Jul 2020800
Aug 20201700
Sep 20202600
Oct 20201200
Nov 20201800
Dec 2020800
Jan 2021200
Feb 2021400
Mar 2021400
Apr 2021600
May 2021300
Jun 2021200
Jul 20211400
Aug 20213300
Sep 20211100
Oct 20211600
Nov 20216700
Dec 20214200
Jan 20226300
Feb 20222100
Mar 20221400
Apr 20221500
May 20222200
Jun 2022300
Jul 2022200
Aug 2022300
Sep 2022200
Oct 2022200
Dec 2022100
Jan 2023100
Feb 2023200
Mar 2023700
Apr 2023100
May 2023200
Jun 2023200
Jul 2023100
Aug 2023400
Sep 2023100
Oct 2023100
Nov 2023300
Dec 2023100
Jan 2024400
Feb 2024100
Mar 2024100
Apr 2024100
May 2024300
Jun 2024100
Jul 2024100
Aug 20241600
Sep 20241000
Nov 2024200
Dec 2024300
Jan 2025300
Feb 2025200
Mar 2025300
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic value of initial PET parameters regarding disease-free survival and overall survival in patients with esophageal squamous cell carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prognostic value of initial PET parameters regarding disease-free survival and overall survival in patients with esophageal squamous cell carcinoma
Charles Lemarignier, Frédéric Di Fiore, Pierre Vera, Bernard Dubray, Pierre Michel
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 72;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic value of initial PET parameters regarding disease-free survival and overall survival in patients with esophageal squamous cell carcinoma
Charles Lemarignier, Frédéric Di Fiore, Pierre Vera, Bernard Dubray, Pierre Michel
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 72;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • The prognostic significance of SUVmax on 18F-FDG PET/CT in early-staged non-small cell lung cancer after SBRT: a meta-analysis
  • F-18 FDG PET/CT evaluation of treatment response to ipilimumab therapy in advanced stage melanoma
  • Analytics in predicting progression-free survival and distant metastasis after chemoradiotherapy using spatial-temporal FDG-PET/CT features
Show more Oncology: Clinical Diagnosis

Gastroesophageal/Pancreatic Cancer

  • Combination of baseline 18F-FDG intra-tumor uptake heterogeneity indices derived from genetic algorithm predicts therapy response and survival in esophageal cancer
  • Prognostic value of nodal SUVmax on pretreatment F-18 FDG PET/CT in patients with gastric cancer
  • Glucose level incorporated maximum standardized uptake value (glu-SUVmax) is the most important predictor of overall survival of surgically resected pancreatic cancer
Show more Gastroesophageal/Pancreatic Cancer

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire